InvestSMART

Micro-X Limited (ASX:MX1)

ALERT: Price-sensitive ASX Announcement for MX1
Current share price for MX1 : $0.048 0.021 (77.78%)+
Announcement
Release
31 Jul 2026 5:31PM
Price at Release
$0.027
Full Release
download
Summary
Micro-X Limited, an Australian hi-tech company specializing in cold cathode X-ray technology for health and security markets, released its quarterly activities report and Appendix 4C for the quarter ended 30 June 2026. Significant achievements include a pilot study for a Head CT device at the Royal Melbourne Hospital, receiving milestone payments from Australian Government programs, and a contract extension from the DHS for threat detection development. Financially, Micro-X reported a cash balance of $3.1 million with expectations of improved cash flow in future quarters due to anticipated R&D tax incentives. The company is exploring additional funding through convertible note placements and has ongoing commercialization efforts, including showcasing its Rover Plus product in international markets.
Key Points
  • Commencement of Head CT human imaging pilot study at Royal Melbourne Hospital.
  • Receipt of $1.5M in milestone payments for Head CT project under government programs.
  • Completion of Full Body CT critical design review, triggering a $1.6M ARPA-H milestone payment.
  • Award of a $1.3M contract extension from DHS to advance threat detection capabilities.
  • Cash balance of $3.1M as of 30 June 2026.
  • Net cash used in operating activities was $3.2M, with expectations of improved cash flows.
  • Convertible note placement to raise additional funds is nearing finalization.
  • Rover Plus showcased at WHX Miami and National Athletic Trainers’ Association conference.
  • Investor Open Day scheduled for early September at Tonsley Innovation Precinct.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.